AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,189 | -69.7% | 8,776 | -62.2% | 0.00% | – |
| Q2 2023 | $224,831 | +17.0% | 23,226 | +32.5% | 0.00% | – |
| Q1 2023 | $192,152 | +765.4% | 17,532 | +241.1% | 0.00% | – |
| Q4 2022 | $22,205 | -99.9% | 5,140 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $37,560,000 | -23.6% | 4,994,705 | +2.2% | 0.00% | -20.0% |
| Q2 2022 | $49,139,000 | -38.5% | 4,889,323 | -24.2% | 0.01% | -16.7% |
| Q1 2022 | $79,897,000 | -39.0% | 6,453,754 | +12.7% | 0.01% | -40.0% |
| Q4 2021 | $131,002,000 | -36.6% | 5,728,116 | -38.6% | 0.01% | -37.5% |
| Q3 2021 | $206,607,000 | +87.0% | 9,336,062 | +9.5% | 0.02% | +77.8% |
| Q2 2021 | $110,458,000 | -8.6% | 8,523,007 | -8.5% | 0.01% | -10.0% |
| Q1 2021 | $120,896,000 | +51.7% | 9,310,445 | +61.6% | 0.01% | +42.9% |
| Q4 2020 | $79,699,000 | +10.8% | 5,762,773 | +18.0% | 0.01% | 0.0% |
| Q3 2020 | $71,922,000 | -25.8% | 4,882,654 | -18.1% | 0.01% | -36.4% |
| Q2 2020 | $96,930,000 | -16.2% | 5,964,923 | -25.2% | 0.01% | -31.2% |
| Q1 2020 | $115,685,000 | -28.9% | 7,972,758 | -0.7% | 0.02% | -11.1% |
| Q4 2019 | $162,689,000 | +2606.1% | 8,030,058 | +613.3% | 0.02% | +1700.0% |
| Q3 2019 | $6,012,000 | -72.3% | 1,125,744 | -65.9% | 0.00% | -66.7% |
| Q2 2019 | $21,715,000 | -26.6% | 3,300,090 | -27.5% | 0.00% | -25.0% |
| Q1 2019 | $29,601,000 | -14.0% | 4,553,903 | -9.8% | 0.00% | -20.0% |
| Q4 2018 | $34,439,000 | +10.8% | 5,049,740 | +7.9% | 0.01% | +66.7% |
| Q3 2018 | $31,082,000 | +20.4% | 4,680,959 | +2.1% | 0.00% | 0.0% |
| Q2 2018 | $25,816,000 | +8.3% | 4,585,309 | -0.2% | 0.00% | 0.0% |
| Q1 2018 | $23,840,000 | +9.5% | 4,593,481 | -4.4% | 0.00% | 0.0% |
| Q4 2017 | $21,764,000 | -40.6% | 4,804,481 | -17.7% | 0.00% | -25.0% |
| Q3 2017 | $36,610,000 | +1.8% | 5,838,831 | -0.5% | 0.00% | 0.0% |
| Q2 2017 | $35,969,000 | -16.2% | 5,867,800 | +0.3% | 0.00% | -20.0% |
| Q1 2017 | $42,928,000 | – | 5,848,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |